Literature DB >> 11055272

Age-period-cohort analyses of breast-, ovarian-, endometrial- and cervical-cancer mortality rates for Caucasian women in the USA.

R E Tarone1, K C Chu.   

Abstract

BACKGROUND: Age-period-cohort analyses of US breast-cancer mortality rates reveal an unexpected decrease in risk for women born after 1948. Hormones are thought to play an important role in the aetiology of breast cancer and female gynaecologic cancers, and thus the evaluation of birth-cohort trends for female gynaecologic cancers may shed light on the declining breast-cancer risk among 'baby-boomers'.
METHODS: Age-period-cohort analyses are applied to US mortality rates for breast cancer, ovarian cancer, endometrial cancer and cervical cancer from 1950 through 1995.
RESULTS: Age-period-cohort analyses provide no clues regarding the declining birth-cohort risk for breast cancer in 'baby-boomers'. The birth-cohort curves for ovarian and endometrial cancers are roughly similar, and largely explained by known risk factors. The calendar-period curve for endometrial cancer reveals increased risk between 1960 and 1980, probably due to increased use of oestrogen replacement therapy. Changes in the birth-cohort curve for cervical cancer reflect, for the most part, changes in sexual activity. An unexpected significant increase in the calendar-period curve for ovarian cancer occurred around 1980.
CONCLUSION: Most of the major changes in the calendar-period and birth-cohort curves for breast cancer and female gynaecologic cancers can be explained by documented changes in known risk factors and in medical practice. The decreasing breast-cancer birth-cohort risk among 'baby-boomers' and the increasing ovarian-cancer calendar-period curve after 1980 are recent changes that require further investigation.

Entities:  

Mesh:

Year:  2000        PMID: 11055272

Source DB:  PubMed          Journal:  J Epidemiol Biostat        ISSN: 1359-5229


  10 in total

1.  Secular trends in adolescent never smoking from 1990 to 1999 in California: an age-period-cohort analysis.

Authors:  Xinguang Chen; Guohua Li; Jennifer B Unger; Xiaowei Liu; C Anderson Johnson
Journal:  Am J Public Health       Date:  2003-12       Impact factor: 9.308

2.  Trends in U.S. adult chronic disease mortality, 1960-1999: age, period, and cohort variations.

Authors:  Yang Yang
Journal:  Demography       Date:  2008-05

Review 3.  Oral contraceptives and cancer: an update.

Authors:  C La Vecchia; A Altieri; S Franceschi; A Tavani
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 4.  Treatment for advanced and recurrent endometrial carcinoma: combined modalities.

Authors:  J Alejandro Rauh-Hain; Marcela G Del Carmen
Journal:  Oncologist       Date:  2010-07-21

5.  Measures of racial/ethnic health disparities in cancer mortality rates and the influence of socioeconomic status.

Authors:  Kenneth C Chu; Barry A Miller; Sanya A Springfield
Journal:  J Natl Med Assoc       Date:  2007-10       Impact factor: 1.798

6.  Recent trends in incidence of cutaneous melanoma among US Caucasian young adults.

Authors:  Mark P Purdue; Laura E Beane Freeman; William F Anderson; Margaret A Tucker
Journal:  J Invest Dermatol       Date:  2008-07-10       Impact factor: 8.551

7.  Comparison of Secular Trends in Cervical Cancer Mortality in China and the United States: An Age-Period-Cohort Analysis.

Authors:  Jinyao Wang; Zhiqiang Bai; Zhenkun Wang; Chuanhua Yu
Journal:  Int J Environ Res Public Health       Date:  2016-11-17       Impact factor: 3.390

8.  DDT and breast cancer.

Authors:  Robert E Tarone
Journal:  Environ Health Perspect       Date:  2008-04       Impact factor: 9.031

9.  Breast Cancer in Canadian Women.

Authors:  Heather Bryant
Journal:  BMC Womens Health       Date:  2004-08-25       Impact factor: 2.809

10.  Temporal Trends of Common Female Malignances on Breast, Cervical, and Ovarian Cancer Mortality in Japan, Republic of Korea, and Singapore: Application of the Age-Period-Cohort Model.

Authors:  Jinyao Wang; Haizhen Lv; Zhilin Xue; Lu Wang; Zhiqiang Bai
Journal:  Biomed Res Int       Date:  2018-03-21       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.